Prescription drug · NDA
Focalin XR (Dexmethylphenidate hydrochloride) NDC 66758-237
Dexmethylphenidate hydrochloride 15 mg/1 · Capsule, Extended release · Oral · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66758-237-01 | 66758023701 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-237-01)Marketed from Oct 4, 2024 | |
| 66758-237-31 | 66758023731 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-237-31)Marketed from Jun 30, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Focalin XRSuffix: XR
- Generic name (nonproprietary)
- dexmethylphenidate hydrochloride
- Active ingredients
- Dexmethylphenidate hydrochloride — 15 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Labeler
- Sandoz IncNDC labeler code 66758
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021802
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Central Nervous System Stimulation (Physiologic effect)
- Identifiers
- Product ID 66758-237_525ad849-4502-493d-a0a1-67cde0a207f0SPL ID 525ad849-4502-493d-a0a1-67cde0a207f0SPL set ID 9cf76f62-48aa-4065-94fd-6fc910391ab5RxCUI 899439, 899441, 899461, 899463, 899485, 899487, 899495, 899497, 899511, 899513, 1006608, 1006610, 1101926, 1101928, 1101932, 1101934UNII 1678OK0E08
- Pharmacologic class
- Central Nervous System Stimulant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466758023701followed by a unit qualifier and the quantityPackage 66758-0237-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Focalin XR is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 )] . Limitations of Use The use of Focalin XR is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 ), Use in Specific Populations ( 8.4 )]. Focalin XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) ( 1 ). Limitations of Use The use of Focalin XR is not recommended in pediatric patients younger th…
Excerpt only. Read the full label for complete information.
About NDC 66758-237
- What is NDC 66758-237?
- 66758-237 is the product NDC for Focalin XR (dexmethylphenidate hydrochloride), Dexmethylphenidate hydrochloride 15 mg/1 capsule, extended release, listed with the FDA by Sandoz Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Focalin XR (Dexmethylphenidate hydrochloride).
- What is the active ingredient?
- Dexmethylphenidate hydrochloride.
- Who is the labeler?
- Sandoz Inc, NDC labeler code 66758. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Focalin XR?
- 15 other product NDCs are listed under this name. See all Focalin XR NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Focalin XR products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0432 | 00078-0432-05 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0608 | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0493 | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-235 | 66758-0235-0166758-0235-31 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-236 | 66758-0236-0166758-0236-31 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-238 | 66758-0238-0166758-0238-31 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-239 | 66758-0239-0166758-0239-31 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-240 | 66758-0240-0166758-0240-31 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-241 | 66758-0241-0166758-0241-31 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-242 | 66758-0242-0166758-0242-31 |
Other NDCs under NDA 021802
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 0781-2729 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0432 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 0781-2730 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0608 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0493 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-235 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-236 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-238 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-239 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-240 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-241 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 66758-242 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0433 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0430 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0609 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0431 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0434 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 0781-2727 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | 0781-2728 |